Effect of Gallium-arsenide low power laser on pain after tympanomastoidectomy

Survey of gallium-arsenide low power laser effect on pain after tympanomastoidectomy surgery: A double-blind randomized clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080831001138N28

Enrollment

128

Registered

2019-09-11

Start date

2018-11-21

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

????? ????? ????. Chronic serous otitis media

Interventions

Intervention 1: “Intervention Group:” Low-power laser radiation with a dose of 8 J/cm2 and 50 MW at 8 points from the back of the ear (four points on the surgical incision behind the ear and two poin

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients 20 to 60 years with postoperative tympanomastoidectomy headache

Exclusion criteria

Exclusion criteria: Patients with bell's paralysis Patients with various types of neuralgia Patients with corticosteroids drug consumption Patients with various types of tumors and malignancies

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Evaluation of pain intensity before laser therapy, in the first session after laser therapy, in the fifth session of laser therapy sessions and after the completion of laser therapy sessions are performed. In the end, the patient's pain relief ratio is measured from the beginning of the study to the end of all sessions. Method of measurement: The visual analog scale (VAS) questionnaire and Headache section from disability neck disability index (NDI).	—

Measure

Time frame

Pain. Timepoint: Evaluation of pain intensity before laser therapy, in the first session after laser therapy, in the fifth session of laser therapy sessions and after the completion of laser therapy sessions are performed. In the end, the patient's pain relief ratio is measured from the beginning of the study to the end of all sessions. Method of measurement: The visual analog scale (VAS) questionnaire and Headache section from disability neck disability index (NDI).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShadman Nemati

Rasht University of Medical Sciences

nemati@gums.ac.ir+98 13 3322 5242

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026